Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/ACM) – Dr Rachel Bastiaenen

Dr Bastiaenen introduces the diagnosis, and treatment for arrhythmogenic cardiomyopathy. Help us be there for everyone that needs us through a one-off donation or a regular gift – https://www.cardiomyopathy.org/donate Chapters: 00:01:54 – What is arrhythmogenic right ventricular cardiomyopathy? 00:09:10 – Recognition of left-sided disease 00:10:49 – 2023 ESC Guidelines for Management of Cardiomyopathies 00:12:24 – Genetics 00:18:08 – Diagnosis 00:30:35 – Lifestyle and exercise 00:32:17 – Treatment options 00:34:56 – Risk stratification 00:36:47 – ICD 00:37:40 – Psychological support 00:39:40 – New developments and future directions Audience questions 00:46:53 – What developments have taken place in ICDs? 00:48:25 – Do all ICDs pace and shock? 00:49:40 – What do the new classifications around ARVC mean? 00:52:00 – Is gene therapy available for ARVC? 00:52:55 – Will there be personalised treatment for ARVC? 00:54:30 – Is anyone using AI in treatment? 00:55:12 – What is the importance of inflammation in ARVC? Dr Rachel Bastiaenen is a Consultant Cardiologist at Guy’s and St Thomas’ NHS Foundation Trust where she is the Clinical Director for Cardiovascular at Guy’s and St Thomas’. She is an Honorary Senior Lecturer at King’s College London. She studied at Peterhouse Cambridge and Imperial College London. She completed her cardiology training in the London Deanery and a Fellowship in Vancouver. Her PhD was awarded from St George’s University of London and involved non-invasive risk stratification of patients with cardiomyopathy. She has presented her work at national and international conferences and has a series of publications in peer reviewed journals. Her PhD was awarded from St George’s University of London in 2014. She has ongoing research interests in arrhythmogenic right ventricular cardiomyopathy and Brugada syndrome. Find out more at www.cardiomyopathy.org